Publications

The G-FINDER Report 2009
Moran M, Guzman J, Henderson K, Ropars AL, McDonald A, McSherry L, Wu L, Omune B, Illmer A, Sturm T, Zmudzki F (2009) Neglected disease research and development: New times, new trends, The George Institute for International Health. December 2009

G FINDER 2009 Neglected disease R D New times new trends

Moran M, Guzman J, Henderson K, McDonald A, Omune B (2009). Giving innovation a push: public and philanthropic R&D funding. Global Forum Update on Research for Health 6. Global Forum for Health Research.

Giving innovation a push Public and philanthropic R D funding

The G-FINDER Report
Moran M, Guzman J, Ropars AL, McDonald A, Sturm T, Jameson N, Wu L, Ryan S, Omune B (2009) Neglected disease research and development: how much are we really spending? The George Institute for International Health. February 2009.
[ Neglected_disease_RD_how_much_are_we_really_spending ]

The G-FINDER PLoS article
Moran M, Guzman J, Ropars AL, McDonald A, Jameson N, et al. (2009) Neglected disease research and development: how much are we really spending? PLoS Med 6(2): e1000030
[http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.1000030]

Moran M, Guzman J, Ropars A, Jorgensen M, McDonald A, Potter S and Haile-Selassie H (2008) Clinical trial site capacity for malaria product development. Health Partnerships Review: Focusing collaborative efforts on research and innovation for the health of the poor. Global Forum for Health Research.
[ Clinical_trial_site_capacity_for_malaria_product_development ]

Moran M, Ropars AL, Guzman J (2007). Partnership dynamics, issues and challenges. Global Forum Update on Research for Health Volume 4. Global Forum for Health Research.

[ Partnership_dynamics_issues_and_challenges ]

Moran M, Guzman J, Ropars A, Jorgensen M, McDonald A, Potter S and Haile-Selassie H (2007) The malaria product pipeline: planning for the future. The George Institute for International Health. September 2007.
[ The malaria product pipeline_planning for the future ]

Moran M, Guzman J, Ropars A and Evans A (2007) Neglected Diseases, Doctors Can Make a Difference. British Medical Association. 2007.
[ Neglected diseases, doctors can make a difference ]
Reproduced with permission from the British Medical Association

Moran M and Guzman J (2006) Drug R&D for neglected diseases by public-private partnerships: are public funds appropriately distributed? Monitoring Financial Flows for Health Research 2005:Behind the Global Numbers. Global Forum for Health Research. February 2006.
[ Drug R_D for neglected diseases by public private partnerships are public funds appropriately distributed ]
Reproduced with permission from the Global Forum for Health Research

Moran M (2006) The New Landscape of Neglected Disease Drug Development. Annual Report 2005. Medicines for Malaria Venture. April 2006.
[ The New Landscape of Neglected Disease Drug Development 2006 ]

Moran M, Ropars AL, Guzman J, Diaz J and Garrison C (2005) The new landscape of neglected disease drug development. London School of Economics and The Wellcome Trust. September 2005.
[ The New Landscape of Neglected Disease Drug Development 2005 ]

Moran M, Ropars AL, Guzman J, Diaz J and Garrison C (2005) Executive summary for the new landscape of neglected disease drug development. London School of Economics and The Wellcome Trust. September 2005.
[ Exec Summary The new landscape of neglected disease drug development ]

Moran M and Guzman J (2005) Neglected disease drug development: How big is the gap? Forum 9. Global Forum for Health Research. September 2005.
[ Forum 9_Neglected disease drug development How big is the gap ]

Moran M (2005) A breakthrough in R&D for neglected diseases: New ways to get the drugs we need. PLoS Med 2(9): e302.
[ A Breakthrough in R_D for Neglected Diseases new ways to get the drugs we need ]

Moran M (2005) Fast Track Options (FTO) as a fundraising mechanism to support R&D into Neglected Diseases. Geneva. CIPIH submission. January 2005.
[ Fast Track Options as a fundraising mechanism to support R_D into Neglected Diseases ]